This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB02628/identifier/pdb/
n10http://bio2rdf.org/drugbank:
n11http://linked.opendata.cz/resource/drugbank/drug/DB02628/identifier/bindingdb/
n13http://linked.opendata.cz/resource/drugbank/drug/DB02628/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n7http://linked.opendata.cz/resource/drugbank/drug/DB02628/identifier/pubchem-substance/
n9http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n15http://linked.opendata.cz/resource/drugbank/drug/DB02628/identifier/drugbank/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n14http://linked.opendata.cz/resource/drugbank/drug/DB02628/identifier/chemspider/

Statements

Subject Item
n2:DB02628
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n9:DB02628 n10:DB02628
dcterms:title
1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide
adms:identifier
n7:46505788 n11:13166 n12:998 n13:4369343 n14:3571936 n15:DB02628
n3:IUPAC-Name
n4:271B4931-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4937-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4936-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4933-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4934-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4935-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B492F-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4930-363D-11E5-9242-09173F13E4C5 n4:271B492D-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B492E-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B493D-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B493E-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4938-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4939-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B493B-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B493A-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B493C-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4943-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4945-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4946-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4942-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4941-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4944-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4932-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B493F-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4940-363D-11E5-9242-09173F13E4C5